Teradyne (TER) PT Raised to $125 at TD Cowen

TD Cowen analyst Krish Sankar raised the price target on Teradyne (NASDAQ: TER) to $125.00 (from $115.00) while maintaining a Buy rating.

The analyst commented: 'With a positive June '24 Q guide and CY24 revenues to grow LSD Y/Y (prior view was flat), Teradyne seems to have passed through the cyclical bottom during the March '24 quarter. We expect HBM testing, Industrial Automation to lead C2H growth while Mobility test is likely a CY25 story. Reiterate Buy; Price Target moves to $125."

You May Also Be Interested In

• argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
• BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
• Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold